Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. Yoo S, Oh S, Suh J, Park J, Cho MC, Jeong H, Won S, Son H (2020) Optimal high-density lipoprotein cholesterol level for decreasing benign prostatic hyperplasia in men not taking statin medication: a historical cohort study. Prostate 80(7):570–576
2. Shih HJ, Tsai PS, Wen YC, Kao MC, Fan YC, Huang CJ (2020) Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. Aging Male 23(5):354–361
3. Besiroglu H, Dursun M, Otunctemur A, Ozbek E (2017) The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study. Aging Male 20(3):198–204
4. Feng T, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ (2017) Serum cholesterol and risk of lower urinary tract symptoms progression: results from the reduction by dutasteride of prostate cancer events study. Int J Urol 24(2):151–156
5. Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M (2015) Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int 115(1):24–31
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献